News

Nearly 40 life-saving medications manufactured by Glenmark Pharmaceuticals Inc. have been recalled by the U.S. Food and Drug ...
According to the USFDA, a Class II recall is issued when the use of or exposure to a violative product may cause temporary or ...
Glenmark Pharmaceuticals has appointed Anurag Mantri president as part of a major leadership transition, with long-serving ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Glenmark Pharmaceuticals has recalled two dozen generic ...
The Healthy @Reader's Digest on MSN21h
3 Popular Pain Relievers Have Been Recalled Nationwide
They're a group of over-the-counter meds that are arguably the most trusted to soothe aches and fever—and two major stores ...
Glenmark Pharmaceuticals has voluntarily recalled 24 generic prescription drugs distributed in the U.S. following concerns about potential cross-contamination at a manufacturing facility in Pithampur, ...
Glenmark Pharmaceuticals has voluntarily recalled 24 generic prescription drugs distributed in the U.S. following concerns about potential cross-contamination at a manufacturing facility in ...
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...
Glenmark Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹1373.5. The stock has experienced fluctuations today ...
Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. As per the ...
On April 7, 2025, Glenmark Pharmaceuticals unveiled a significant change in its leadership with the appointment of Anurag Mantri as President and the departure of long-time Chief Financial ...
Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...